نتایج جستجو برای: liver fibrosis

تعداد نتایج: 410943  

Journal: :Translational research : the journal of laboratory and clinical medicine 2015
Christopher Sjöwall Klara Martinsson Kristina Cardell Mattias Ekstedt Stergios Kechagias

The identification of individuals with severe liver fibrosis among patients with chronic liver disease is of major importance when evaluating prognosis, potential risk for complications, and when deciding treatment strategies. Although percutaneous liver biopsy is still considered a "gold standard" for staging of liver fibrosis, attempts to find reliable noninvasive markers of liver fibrosis ar...

2016
Florian Bert Jona T. Stahmeyer Siegbert Rossol

BACKGROUND Early discovery of liver fibrosis is becoming more popular because of enhanced incidence of hepatocellular carcinoma. Ultrasound-based liver elastography is a method used to approve suspected liver fibrosis or cirrhosis. We assessed the clinical usefulness of acoustic radiation force impulse shear wave elasticity imaging (ARFI-SWEI) as a preventive screening method to uncover fibrosi...

Journal: :Translational research : the journal of laboratory and clinical medicine 2010
Valerio Nobili Anna Alisi Giuliano Torre Rita De Vito Andrea Pietrobattista Giuseppe Morino Jean De Ville De Goyet Giorgio Bedogni Massimo Pinzani

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in children and adolescents, and it may progress to liver fibrosis and cirrhosis. Liver biopsy, which is the recognized gold standard for the diagnosis of hepatic fibrosis, is invasive. Thus, there has been increasing interest in the development of noninvasive markers. Hyaluronic acid (HA) has been shown to be a g...

2016
Seiichi Tawara Tomohide Tatsumi Sadaharu Iio Ichizou Kobayashi Minoru Shigekawa Hayato Hikita Ryotaro Sakamori Naoki Hiramatsu Eiji Miyoshi Tetsuo Takehara

Fucosylated haptoglobin (Fuc-Hpt) and Mac-2 binding protein (Mac-2 bp) are identified as cancer biomarkers, based on the results from a glyco-proteomic analysis. Recently, we reported that these glyco-biomarkers were associated with liver fibrosis and/or ballooning hepatocytes in patients with nonalcoholic fatty liver disease (NAFLD). We evaluated the ability of these glycoproteins to estimate ...

2012
Xin Hou Fazhi Yu Suqin Man Dake Huang Yuxia Zhang Miao Liu Cuiping Ren Jijia Shen

The role of natural killer (NK) cells in infection-induced liver fibrosis remains obscure. In this study, we elucidated the effect of NK cells on Schistosoma japonicum (S. japonicum) egg-induced liver fibrosis. Liver fibrosis was induced by infecting C57BL/6 mice with 18-20 cercariae of S. japonicum. Anti-ASGM1 antibody was used to deplete NK cells. Toll-like receptor 3 ligand, polyinosinic-pol...

2016
Bin-bin Li Dong-liang Li Chao Chen Bao-hai Liu Chun-yan Xia Han-jun Wu Chao-qun Wu Guo-qin Ji Su Liu Wu Ni Ding-kang Yao Zhi-yu Zeng Da-gui Chen Bao-dong Qin Xuan Xin Gang-li Yan Dan Tang Hui-min Liu Jin He Hongli Yan Wei-Jian Zhu Hong-yu Yu Liang Zhu

Early diagnosis of liver fibrosis is critical for early intervention and prognosis of various chronic liver diseases. Conventional repeated histological assessment is impractical due to the associated invasiveness. In the current study, we evaluated circulating miR-185 as a potential biomarker to predict initiation and progression of liver fibrosis. We found that miR-185 was significantly up-re...

2008
P. Asbach D. Klatt C. Kamphues P. Neuhaus J. Braun

Background and Purpose: Liver transplantation is an ultimate therapeutic option for end-stage liver disease. In the context of liver cirrhosis caused by viral hepatitis, it is known that re-infection of the graft occurs frequently and that progression of fibrosis advances more quickly in the transplanted organ [1]. Therefore, a closer follow-up is necessary including frequent biopsies for gradi...

2014
Ikuo Nakamura Kais Zakharia Bubu A. Banini Dalia S. Mikhail Tae Hyo Kim Ju Dong Yang Catherine D. Moser Hassan M. Shaleh Sarah R. Thornburgh Ian Walters Lewis R. Roberts

BACKGROUND AND AIMS Brivanib is a selective inhibitor of vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) tyrosine kinases, which are both involved in mechanisms of liver fibrosis. We hypothesized that inhibition of VEGFR and FGFR by brivanib would inhibit liver fibrosis. We therefore examined the effect of brivanib on liver fibrosis in three mous...

2012
Min Cong Keiko Iwaisako Chunyan Jiang Tatiana Kisseleva

Liver fibrosis is the result of the entire organism responding to a chronic injury. Every cell type in the liver contributes to the fibrosis. This paper first discusses key intracellular signaling pathways that are induced during liver fibrosis. The paper then examines the effects of these signaling pathways on the major cell types in the liver. This will provide insights into the molecular pat...

Journal: :Journal of hepatology 2013
Erawan Borkham-Kamphorst Henning W Zimmermann Nikolaus Gassler Ute Bissels Andreas Bosio Frank Tacke Ralf Weiskirchen Sandip M Kanse

BACKGROUND & AIMS Factor VII activating protease (FSAP) is a circulating serine protease produced in the liver. A single nucleotide polymorphism (G534E, Marburg I, MI-SNP) in the gene encoding FSAP (HABP2) leads to lower enzymatic activity and is associated with enhanced liver fibrosis in humans. FSAP is activated by damaged cells and its substrates include growth factors and hemostasis protein...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید